Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| LISINOPRIL (TYPE Z) | sanis health inc | Marketed | Apr 12, 2022 | Marketed |
| LISINOPRIL (TYPE Z) | sanis health inc | Marketed | Apr 12, 2022 | Marketed |
| HULIO | Biosimilar Collaborations Ireland Ltd. | Marketed | Apr 11, 2022 | Marketed |
| DIACETYLMORPHINE HYDROCHLORIDE | Pharmascience Inc | Marketed | Apr 11, 2022 | Marketed |
| MAR-CLONIDINE | marcan pharmaceuticals inc | Marketed | Apr 11, 2022 | Marketed |
| ACID CONCENTRATE A1245 | chief medical supplies ltd | Cancelled Post Market | Apr 11, 2022 | Cancelled Po... |
| URBAN ENVIRONMENT OIL-FREE | shiseido americas corporation dist | Marketed | Apr 8, 2022 | Marketed |
| SENSITIVE EXPERT+ SUNSCREEN | ombrelle canada | Marketed | Apr 8, 2022 | Marketed |
| PERINDOPRIL ERBUMINE/INDAPAMIDE HD | PRO DOC LIMITEE | Marketed | Apr 8, 2022 | Marketed |
| SENSITIVE EXPERT+ FACE | ombrelle canada | Marketed | Apr 8, 2022 | Marketed |
| MINT-QUETIAPINE XR | mint pharmaceuticals inc | Dormant | Apr 7, 2022 | Dormant |
| MINT-QUETIAPINE XR | mint pharmaceuticals inc | Marketed | Apr 7, 2022 | Marketed |
| SANDOZ LURASIDONE | Sandoz Canada, Inc. | Marketed | Apr 7, 2022 | Marketed |
| SANDOZ LURASIDONE | Sandoz Canada, Inc. | Marketed | Apr 7, 2022 | Marketed |
| MINT-QUETIAPINE XR | mint pharmaceuticals inc | Marketed | Apr 7, 2022 | Marketed |
| SANDOZ LURASIDONE | Sandoz Canada, Inc. | Marketed | Apr 7, 2022 | Marketed |
| SANDOZ LURASIDONE | Sandoz Canada, Inc. | Marketed | Apr 7, 2022 | Marketed |
| MINT-QUETIAPINE XR | mint pharmaceuticals inc | Marketed | Apr 7, 2022 | Marketed |
| COOLA SCALP MIST SUNSCREEN SPF 30 OCEAN SALTED SAGE SCENT | coola llc | Marketed | Apr 5, 2022 | Marketed |
| MAR-ONDANSETRON ODT | marcan pharmaceuticals inc | Marketed | Apr 5, 2022 | Marketed |
